|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.47 CNY | +0.44% |
|
+0.10% | -5.23% |
Business description: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Number of employees: 988
Sales by Activity: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
| Fiscal Period: December | 2020 (CNY) | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) |
|---|---|---|---|---|---|
Dietary Fiber Series | 193M | 293M | 339M | 444M | 624M |
Prebiotics Series | 250M | 239M | 246M | 257M | 322M |
Healthy Sweetener Series | 9.75M | 83M | 94.7M | 137M | 156M |
Other Starch Sugar (Alcohol) | 38.1M | 24.45M | 16.62M | 15.7M | 4.32M |
Geographical breakdown of sales: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
| Fiscal Period: December | 2020 (CNY) | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) |
|---|---|---|---|---|---|
Overseas | 212M | 363M | 356M | 441M | 698M |
Huadong Region | 130M | 122M | 188M | 224M | 209M |
Central China | 28.77M | 42.4M | 46.56M | 62.17M | 72.55M |
Southern China | 37.92M | 30.94M | 35.57M | 41.52M | 38.01M |
North China | 28.79M | 30.51M | 27.9M | 25.75M | 34.68M |
Northwestern China | 32.85M | 33.57M | 25.01M | 34.63M | 30.85M |
Northeast China | 14.61M | 9.72M | 8.77M | 16.9M | 17.08M |
Southwest China | 6.34M | 7.17M | 7.93M | 8.43M | 6.48M |
Executive Committee: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Jian Zhuo
CEO | Chief Executive Officer | 48 | 2018-06-17 |
Li Li
DFI | Director of Finance/CFO | 48 | 2017-03-31 |
De Shan Zhang
PRN | Corporate Officer/Principal | 49 | 2006-05-31 |
Wen Ping Yu
PRN | Corporate Officer/Principal | 40 | 2006-09-30 |
Lian Lian An
IRC | Investor Relations Contact | 50 | 2012-06-30 |
Composition of the Board of Directors: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Bao De Dou
CHM | Chairman | 62 | 2016-09-24 |
Hong Jian Zhuo
BRD | Director/Board Member | 48 | 2016-09-24 |
Lian Lian An
BRD | Director/Board Member | 50 | 2016-09-24 |
Xin Rong Wang
BRD | Director/Board Member | 45 | 2016-09-24 |
Wei Tao Qi
BRD | Director/Board Member | 45 | 2017-09-09 |
Zhao Zhang
BRD | Director/Board Member | 53 | 2018-11-26 |
Xia Jiang
BRD | Director/Board Member | 61 | 2016-09-24 |
Wan Qing Zheng
BRD | Director/Board Member | 64 | 2016-09-24 |
Wen Ping Yu
BRD | Director/Board Member | 40 | 2016-08-31 |
De Shan Zhang
BRD | Director/Board Member | 49 | 2019-09-24 |
Company details: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Dexin Street
251200, Dezhou
+86 53 4821 5064
http://www.chinabailong.com/
Sugar & Artificial Sweeteners
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.44% | +0.10% | +63.26% | +96.96% | 1.23B | ||
| +4.72% | +3.00% | +90.61% | +273.32% | 2.34B | ||
| +0.90% | +3.94% | -6.69% | -37.36% | 2.24B | ||
| 0.00% | +1.40% | +0.96% | +17.32% | 2.16B | ||
| -1.17% | +9.48% | -14.93% | +0.60% | 1.21B | ||
| +0.11% | +12.06% | +109.43% | +317.11% | 1.2B | ||
| -0.26% | +4.59% | +35.31% | +13.16% | 1.01B | ||
| +5.40% | +12.60% | -33.94% | -28.57% | 1B | ||
| 0.00% | +0.00% | +71.96% | +331.52% | 959M | ||
| -0.04% | -2.94% | -14.44% | +7.89% | 951M | ||
| Average | +1.01% | +3.80% | +30.15% | +99.19% | 1.43B | |
| Weighted average by Cap. | +1.22% | +3.60% | +31.30% | +98.27% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Annual profits - Rate of surprise
- Stock Market
- Equities
- 605016 Stock
- Company Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions

















